Postoperative Outcomes and Strategic Refinement in Intraductal Papillary Mucinous Neoplasm Management: A Single Academic Cancer Center Experience
Cancer Diagnosis & Prognosis · 01.03.2026 · 6 (2) · 291-302
DOI: 10.21873/cdp.10528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.03.2026. Verfasst von Atsushi Nanashima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-biliary-pancreas Surgery, Department of Surgery. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is a precursor lesion with variable malignant potential. Due to its heterogeneity, optimal treatment strategies remain controversial, especially regarding surgical resection and surveillance indications. We reviewed our institutional outcomes to reassess the current postoperative strategy and refine management guidelines. Patients and Methods: This study retrospectively and consecutively analyzed the data of 49 IPMN patients who underwent pancreatectomy at an academic institution from 2015 to May 2025. Results: Diagnostic mismatch between preoperative and final pathological findings was observed in 39% of cases, with overdiagnosis (downgrade group) being more common than underdiagnosis. Overdiagnosed cases were significantly associated with main pancreatic duct dilation (>5 mm) (p=0.012) and elevated amylase levels (p=0.031), while the only upgraded case involved invasive carcinoma with mural nodule and Sonazoid enhancement. Histological grade strongly influenced prognosis: Patients with adenoma or carcinoma in situ showed favorable outcomes (5-year OS ≥89%), whereas those with invasive IPMN had markedly worse survival (5-year OS 36%; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepato-biliary-pancreas Surgery, Department of Surgery.
- Department of Clinical Oncology, and 3Division of Gastroenterology and Hepatology.
- Department of Internal Medicine, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
Zitieren
APA
Nanashima, A., Imamura, N., Hiyoshi, M., Tsuchimochi, Y., Wada, T., Hamada, T., Suzuki, Y., Araki, Y., Hosokawa, A., & Kawakami, H. (2026). Postoperative Outcomes and Strategic Refinement in Intraductal Papillary Mucinous Neoplasm Management: A Single Academic Cancer Center Experience. Cancer Diagnosis & Prognosis, 6(2), 291-302. https://doi.org/10.21873/cdp.10528
Vancouver
Nanashima A, Imamura N, Hiyoshi M, Tsuchimochi Y, Wada T, Hamada T, et al. Postoperative Outcomes and Strategic Refinement in Intraductal Papillary Mucinous Neoplasm Management: A Single Academic Cancer Center Experience. Cancer Diagnosis & Prognosis. 2026;6(2):291-302. doi:10.21873/cdp.10528
BibTeX
@article{Nanashima2026,
author = {Nanashima, Atsushi and Imamura, Naoya and Hiyoshi, Masahide and Tsuchimochi, Yuki and Wada, Takashi and Hamada, Takeomi and Suzuki, Yasuyuki and Araki, Yuusuke and Hosokawa, Ayumu and Kawakami, Hiroshi},
title = {Postoperative Outcomes and Strategic Refinement in Intraductal Papillary Mucinous Neoplasm Management: A Single Academic Cancer Center Experience},
journal = {Cancer Diagnosis & Prognosis},
year = {2026},
volume = {6},
number = {2},
pages = {291--302},
doi = {10.21873/cdp.10528}
}
EUVIMED